Antidepressants and gene expression profiling: How to SNARE novel drug targets

Pharmacogenomics Journal

Volumn 2, Issue 6, 2002, Pages 346-348

  Lesch, K P ^a   Schmitt, A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMIPRAMINE; IMMEDIATE EARLY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOAMINE OXIDASE INHIBITOR; NERVE GROWTH FACTOR; PROTEIN C FOS; PROTEIN C JUN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SNARE PROTEIN; STAT PROTEIN; SYNAPTOBREVIN; SYNAPTOBREVIN 2; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; SYNTAXIN 1; TRANSCRIPTION FACTOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG;

ADAPTATION; CELL PROLIFERATION; CELL SURVIVAL; DEPRESSION; DRUG MECHANISM; DRUG TARGETING; ELECTROCONVULSIVE THERAPY; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPHYSIOLOGY; NEUROPROTECTION; NOTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; DRUG DELIVERY SYSTEMS; GENE EXPRESSION PROFILING; HUMANS; MEMBRANE PROTEINS; SNARE PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 0036986331     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500150     Document Type: Note

References (17)

1. Yamada M et al. Pharmacogenomics J 2002; 2: 377-382.
2. Südhof TC. Nature 1995; 375: 645-653.
3. Mochida S. Neurosci Res 2000; 36: 175-182.
4. Yamada M et al. Neurosci Lett 2001; 301: 183-186.
5. Blier P, de Montigny C. Biol Psychiatry 1998; 44: 313-323.
6. Lesch KP et al. Mol Brain Res 1993; 17: 31-35.
7. Benmansour S et al. J Neurosci 2002; 22: 6766-6772.
8. Lesch KP et al. Psychopharmacology 1991; 105: 415-420.
9. Nibuya M et al. J Neurosci 1996; 16: 2365-2372.
10. Morinobu S et al. Synapse 1997; 25: 313-320.
11. Lesch KP & Heils A. Int J Neuropsychopharmacol 2000; 3: 67-79.
12. Kim SW et al. Mol Pharmacol 2002; 61: 778-785.
13. Nibuya M et al. J Neurosci 1995; 15: 7539-7547.
14. Vaidya VA et al. Neuroscience 1999; 89: 157-166.
15. Malberg JE et al. J Neurosci 2000; 20: 9104-9110.
16. Gould E. Neuropsychopharmacol 1999; 21: 46S-51S.
17. Lesch KP. Eur J Neuropsychopharmacol 2001; 11: 457-474.